DeltaWave shared its perspective at the first European Deeptech Week, an event that captured the momentum building across the continent.

The message centered on patient capital, public-private risk sharing, and the need for sovereign training infrastructure behind European AI. EVE and PCP were presented as DeltaWave's answer for molecular R&D: agentic AI at the application layer and distributed training at the infrastructure layer.

The discussion also highlighted Franco-German cooperation between Bpifrance and SPRIND, including the memorandum of understanding signed in Berlin in October 2025 and SPRIND's challenge-grant and investor network support for DeltaWave.